Status:
COMPLETED
Oxytocin to Decrease Blood Loss During Cesarean Section
Lead Sponsor:
American University of Beirut Medical Center
Conditions:
Complications; Cesarean Section
Eligibility:
FEMALE
15-45 years
Phase:
NA
Brief Summary
The goal of this study is to determine the best dose of a drug called oxytocin, that is usually used to stop bleeding during a delivery, when used during a cesarean delivery. It will be administered d...
Detailed Description
This trial will be a randomized, blinded controlled trial that will be conducted at the American University of Beirut Medical Center Labor and Delivery Unit. Identification of candidates: * All wome...
Eligibility Criteria
Inclusion
- Study subjects will be women delivering via an elective cesarean section at term
- All study subjects will have singleton gestation with no obstetric or medical complication.
Exclusion
- Laboring women
- Multifetal gestation
- Prolonged oxytocin use (\>12 hours)
- Hypertensive disorders
- Chorioamnionitis
- Suspected macrosomia
- Polyhydramnios
- History of postpartum Hemorrhage
- Clotting disorder
- Intake of magnesium sulfate
- Uterine fibroids
- Placenta previa
- Placental abruption
- Anticoagulation
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2013
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00891150
Start Date
July 1 2012
End Date
February 1 2013
Last Update
March 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American University of Beirut Medical Center
Beirut, Lebanon